EB

Emergent Biosolutions

EBS

NYSEHealth Care

Income Statement

Total Revenue$1.04B

Gross Profit$362.3M

Operating Income$-108.7M

EBITDA$36.9M

EBIT$-71.9M

Pre-tax Income$3.5M

Net Income$-190.6M

Balance Sheet

Cash Equivalent$103M

Total Debt$773.6M

Book Value$510.35M

Book Value Per Share9.64

Key Ratios

Return on Equity (ROE)-39.48%

Return on Assets (ROA)-13.72%

Return on Invested Capital (ROI)-16.62%

Net Profit Margin-18.26%

Current Ratio3.69

Quick Ratio1.60

Long-Term Debt / Equity1.37